nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma

OBJECTIVES: We previously reported the efficacy of nab-paclitaxel added to cisplatin, 5-FU, and cetuximab (APF-C) followed by concurrent high dose bolus cisplatin and radiation therapy (CRT) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). In this phase II trial, we d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oral Oncol
Hlavní autoři: Adkins, Douglas, Ley, Jessica, Michel, Loren, Wildes, Tanya M., Thorstad, Wade, Gay, Hiram A., Daly, Mackenzie, Rich, Jason, Paniello, Randal, Uppaluri, Ravindra, Jackson, Ryan, Trinkaus, Kathryn, Nussenbaum, Brian
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5105832/
https://ncbi.nlm.nih.gov/pubmed/27688097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2016.07.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky